Will the U.S. Department of Commerce publish the final determination on N-Cyclohexylbenzothiazole-2-Sulfenamide CVD from China by 2026-11-07?
Posted 2026-10-08 — 30 days before the deadline, stated before the outcome.
The U.S. Department of Commerce conducts countervailing duty investigations to assess whether imports receive subsidies from foreign governments. Such investigations may result in duties if subsidies are found and domestic industry injury is determined. The matter at hand involves the chemical N-Cyclohexylbenzothiazole-2-Sulfenamide imported from China.
The claim
The U.S. Department of Commerce will publish the final determination for the countervailing duty investigation of N-Cyclohexylbenzothiazole-2-Sulfenamide from China by 2026-11-07.
Reasoning trace
- Preliminary affirmative CVD determination for CBS from China published on Oct 8
- Commerce completes administrative process and issues final rule per statutory timeline
- Final CVD determination for CBS published
Evidence so far
0 confirming · 0 denying signals · 1 verified · 1 broken assumptions. The evidence itself is part of the full dossier.
Probability history
Updated 1 time since mint (last on 2026-10-08) — 84% at mint → 78% today.
What to watch
- leading indicator The U.S. Department of Commerce publishes a notice in the Federal Register announcing the final determination for the countervailing duty investigation of N-Cyclohexylbenzothiazole-2-Sulfenamide from China
- milestone The U.S. Department of Commerce publishes the final determination for the countervailing duty investigation of N-Cyclohexylbenzothiazole-2-Sulfenamide from China in the Federal Register
- milestone The U.S. Department of Commerce publishes a notice in the Federal Register stating that the administrative record for the N-Cyclohexylbenzothiazole-2-Sulfenamide CVD investigation is closed
The full dossier behind this prediction — the evidence trail, the risk analysis, the monetization scenarios — is available on request: [email protected].
Probabilities are calibrated against the system's own resolved history; after the deadline the outcome is resolved and audited — including the calls we get wrong. Nothing on this page is investment advice.